Case Reports Journal Article Ahead of print
PubMed: 40996403 DOI: 10.1016/j.jaccas.2025.105531
Late Thrombosis of First-Generation Bioresorbable Scaffold Site Treated With Novel Resorbable Magnesium Scaffold.
JACC Case Rep
Authors: Jorgo Kostov, Biljana Zafirovska, Sasko Kedev
Affiliations
- Faculty of Medicine, University Clinic of Cardiology, University of St Cyril & Methodius, Skopje, Macedonia.
- Faculty of Medicine, University Clinic of Cardiology, University of St Cyril & Methodius, Skopje, Macedonia.
Abstract
BACKGROUND
To the best of our knowledge, this is the first reported experience of a patient with late thrombosis of previous Absorb (Abbott Vascular) bioresorbable scaffold (BRS) implantation site, treated with second-generation Magmaris (Biotronik) resorbable magnesium scaffold (RMS).
CASE SUMMARY
A 55-year-old man with a previously implanted Absorb BRS stent presented with a non-ST-elevation myocardial infarction. Coronary angiography showed thrombotic lesion at the BRS stent site. After intravascular optical coherence tomography (OCT) imaging, a decision was made to implant a second-generation RMS stent. OCT follow-up was performed, with excellent long-term results.
DISCUSSION
Randomized controlled trials have connected early BRS implantation to a higher rate of stent thrombosis. In recent years, the newer generation RMS has confirmed a good safety profile and long-term patency. The idea behind this treatment was to assess the novel RMS technology with serial OCT imaging.
TAKE-HOME MESSAGES
This case adds new options for the treatment of coronary arteries with novel RMS technology. Intravascular imaging with OCT is essential for optimized treatment and follow-up.
MeSH
Stents, Cardiovascular Diseases, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Tomography, Optical Coherence, Therapeutics, Thrombosis